Lupin is launching generic version of sleep disorder Nuvigil tablets in the US market. The brand has an annual market size of $515 million and Lupin is the third company to launch the generic version in the US.
Drug major Lupin on Thursday said its US arm Gavis has received approval from the US health regulator to market hydrocodone bitartrate and acetaminophen tablets, a pain relieving drug, in the American market.
Lupin has surged 8% to Rs 1,535 on BSE, erasing its entire previous weeks’ losses, after the drug maker on Saturday said that it has received Establishment Inspection Report (EIR) from the US health regulator for its Goa plant leading to closure of
Drug major Lupin on Wednesday said its subsidiary Gavis Pharmaceuticals has received approval from the US health regulator to market generic linezolid tablets used for treating bacterial infection in the American market.
Drug firm Lupin on Wednesday said its subsidiary Gavis Pharmaceuticals has received final approval from the US health regulator to market potassium chloride extended release capsules, used for treating potassium deficiency in the bloodstream, in the
Lupin has dipped 5% to Rs 1,607, falling 7% from day’s high on the BSE, after the company reported Ebitda (earnings before interest, taxes, depreciation and amortisation) margin at 32.2% in June 2016 quarter against 32.8% in March 2016 quarter.